Recently, Onkos Surgical received $17.6 million in Series B financing, led by Canaan Partners, 3D systems and 1315 Capital. Founded in 2015 and headquartered in Parsippany, New Jersey, Onkos Surgical specializes in orthopaedic oncology research, providing oncologists with new technologies and solutions to penetrate orthopedic medical devices led by industry giants such as Stryker and Biomet. market.
The company has been working to address the loosening of implants and the body, and this round of financing will use new funds to expand its sales, marketing and R&D platforms. The team is applying for approval from the regulatory authorities and is expected to expand into Western Europe and Australia in 2018.
Solve the problem of loose connection between bone implant and body
Onkos focuses on orthopedic orthopedic oncology research. This has become an abandoned area due to the rapid increase in demand for age-related orthopaedic products and the entry of innovative technologies such as robots.
What problems does Onkos Surgical solve? When a tumor or hyperplastic tissue on a bone is removed, a highly customized implant is typically required to replace the missing portion. In the past, these techniques came from other areas of orthopedics research, but there were still infection problems, implants reattaching soft tissues such as tendons and ligaments, so-called aseptic loosening, loose implants but no infection. In other words, Onkos has been working to solve the problem of loose connection between the implant and the body.
The company's products include the ELEOSTM Limb Rescue System, My3DTM Technology and GenVie. The ELEOSTM Limb Rescue System helps patients who require radical resection and replacement of the femoral condyle to design a surgical plan that accurately calculates how many implants are needed and verifies biomechanical stability, reducing instability and implant dislocation. The system is simple to operate and provides design features.
My3DTM technology helps companies develop personalized implants, medical devices and anatomical models for different patients. CT scans are performed with a high quality image processor to create a 3D computer model of hard and soft (tumor) tissue. The surgeon then works with a technical expert to design a surgical plan based on the model to improve the efficacy of the individual patient.
GenVie provides focus and innovation for musculoskeletology. Bioproducts that develop soft tissue and skeletal oncology applications, complications such as wound closure, bone regeneration, and neurological and soft tissue challenges often require biologic adjuvants to improve healing.
Plant extracts refer to substances extracted or processed from plants (all or a part of plants, such as fruits, leaves, stems, seeds, peels, roots) using appropriate solvents or methods, and can be used in the pharmaceutical industry, food industry, health industry, cosmetic industry and other industries.
Herbal Extract,Herbal Extracts,Herbal Extract Powder,High Purity Active Ingredients Extract Powder
Hunan Insen Biotech Co., Ltd , https://www.insenhealth.com